drug · Product Intelligence

Lisdexamfetamine Dimesylate
Pipeline Intelligence

Lisdexamfetamine Dimesylate: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 5 FDA-linked events where matched.

⚗

3Indexed trials

▦

3Sponsors

⌁

0Orange Book patent links

◎

5FDA-linked events

NCT03337646JPM van Stralen Medicine Professional · autismPHASE4

NCT03926052Yale University · eating_disordersPHASE3

NCT04152629Purdue Pharma, Canada · adhdPHASE4

Orange Book match found; no listed patent relation was retained for this product match.

FDA_APPROVALLISDEXAMFETAMINE DIMESYLATE · 2023-08-25

FDA_APPROVALVYVANSE · 2017-01-28

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.

Lisdexamfetamine DimesylatePipeline Intelligence